Medicare Advantage Is Curbing Opioid Abuse

The drug and medical program gives insurance companies an incentive to take into account the effects of prescription drugs on the cost of care.

Recent data show that drug overdose deaths in the U.S. were 10 percent higher in 2017 than 2016, with an almost 50 percent increase in those related to synthetic opioids. A new research paper points to a glimmer of hope in this otherwise bleak story: Medicare Advantage insurance companies seem to be doing a surprisingly good job at mitigating opioid abuse.

Read Peter Orszag’s full Bloomberg article here.